Location: Detroit
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Detroit
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Karmanos Cancer Institute · Janssen Research & Development, LLC · NCT06319820A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Phase 1/Phase 2 · Karmanos Cancer Institute - Detroit- Site Number : 8400006 · Sanofi · NCT05584670A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · Henry Ford Hospital_Detroit · Novo Nordisk A/S · NCT06612268A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · Henry Ford Health · Johns Hopkins University · NCT07059091Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Children's Hospital of Michigan · New York Blood Center · NCT01656603Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiograp
NA · Henry Ford Health System · Santiago Ortega Gutierrez · NCT06825897Hyperbaric Oxygen Brain Injury Treatment Trial
Phase 2 · Detroit Receiving Hospital · Gaylan Rockswold · NCT02407028Mitral Valve Screening Survey
Phase N/A · Ascension St. John's Hospital · Medstar Health Research Institute · NCT04736667A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · Brigitte Harris Cancer Pavilion · Pfizer · NCT05355701ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NA · Henry Ford Health · JenaValve Technology, Inc. · NCT06608823Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Wayne State University/Karmanos Cancer Institute · National Cancer Institute (NCI) · NCT05987241Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Henry Ford Health System · Gilead Sciences · NCT05633654JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Phase 2 · Henry Ford Health Hospital · PPD Development, LP · NCT06701656A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Karmanos Cancer Institute · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin)
Phase 1/Phase 2 · Karmanos Cancer Institute · Eisai Inc. · NCT04300556MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Detroit Receiving Hospital · Stryker Instruments · NCT03072927Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NA · Henry Ford Health Systems · Insulet Corporation · NCT07579702A Study of ASP1002 in Adults for Treatment of Solid Tumors
Phase 1 · Henry Ford Hospital · Astellas Pharma Global Development, Inc. · NCT05719558Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06961214Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Phase N/A · Henry Ford Health Saint John Hospital · ECOG-ACRIN Cancer Research Group · NCT06002828Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · Wayne State University/Karmanos Cancer Institute · NRG Oncology · NCT04804644Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
Phase 2 · Research Site · AstraZeneca · NCT05952024Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VII
Phase N/A · Children's Hospital of Michigan · Wayne State University · NCT05022459Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT05797168Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Devic
Phase 2 · Karmanos Cancer Institute · Barbara Ann Karmanos Cancer Institute · NCT06576115A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Karmanos Cancer Institute · Hoffmann-La Roche · NCT04929223A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Phase 3 · Henry Ford Cancer Detroit · Janssen Research & Development, LLC · NCT07164443A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectab
Phase 1/Phase 2 · Barbara Ann Karmanos Cancer Institute · Tvardi Therapeutics, Incorporated · NCT05440708A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Br
Phase 1 · Karmanos Cancer Institute · A2A Pharmaceuticals Inc. · NCT06136884
Look up another city
Look up another condition